Ákos Gulybán

Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)

Oscar Matzinger, Irma Heimsoth, Philip Poortmans et al. · Acta Oncologica · 2010 · 118 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Interobserver variability in delineation of target volumes in head and neck cancer

Julie van der Veen, Ákos Gulybán, Sandra Nuyts · Radiotherapy and Oncology · 2019 · 118 citations

Medicine, Oncology, Neoplasia +14

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991

Oscar Matzinger, F. Duclos, A. van den Bergh et al. · European Journal of Cancer · 2009 · 100 citations

Medicine, Oncology, Radiation Oncology +15

Interobserver variability in organ at risk delineation in head and neck cancer

Julie van der Veen, Ákos Gulybán, Siri Willems et al. · Radiation Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review

Oscar Matzinger, Philip Poortmans, Jean-Yves Giraud et al. · Radiotherapy and Oncology · 2008 · 61 citations

Medicine, Surgery, Urology +11